Doh

The Department of Health - Abu Dhabi, Mass General Brigham, and International Center for Genetic Disease sign Declaration of Collaboration to Advance Life Sciences Research

Retrieved on: 
Thursday, June 15, 2023
Interim, International Center, Abu Dhabi Department of Education and Knowledge, Public, Scottish Aquaculture Innovation Centre, ABU, Massachusetts General Hospital, Genomics, United Arab Emirates, Capacity building, Department of Health (Abu Dhabi), DSM-IV codes, Patient, Mass, Mass General Brigham, Emirate, Rare, Doh, Neurology, Technology transfer, Medical device, Research

ABU DHABI, UAE, June 15, 2023 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, signed a Declaration of Collaboration with Mass General Brigham's International Center for Genetic Disease (iCGD).

Key Points: 
  • ABU DHABI, UAE, June 15, 2023 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, signed a Declaration of Collaboration with Mass General Brigham's International Center for Genetic Disease (iCGD).
  • The agreement signed is intended to advance life sciences across three strategic pillars including clinical and translational research, capacity building and technology transfer and commercialisation.
  • The collaboration aims to enhance access to innovative solutions and treatments for patients in the United Arab Emirates (UAE) and beyond.
  • Through our research collaboration with the Abu Dhabi Department of Health we intend to leverage our collective knowledge, experience, and expertise to further advance biomedical science and enhance public health.

The Department of Health - Abu Dhabi, Mass General Brigham, and International Center for Genetic Disease sign Declaration of Collaboration to Advance Life Sciences Research

Retrieved on: 
Wednesday, June 14, 2023
Interim, International Center, Abu Dhabi Department of Education and Knowledge, Public, Scottish Aquaculture Innovation Centre, ABU, Massachusetts General Hospital, Genomics, United Arab Emirates, Capacity building, Department of Health (Abu Dhabi), DSM-IV codes, Patient, Mass, Mass General Brigham, Emirate, Rare, Doh, Neurology, Technology transfer, Medical device, Research

ABU DHABI, UAE, June 14, 2023 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, signed a Declaration of Collaboration with Mass General Brigham's International Center for Genetic Disease (iCGD).

Key Points: 
  • ABU DHABI, UAE, June 14, 2023 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, signed a Declaration of Collaboration with Mass General Brigham's International Center for Genetic Disease (iCGD).
  • The agreement signed is intended to advance life sciences across three strategic pillars including clinical and translational research, capacity building and technology transfer and commercialisation.
  • The collaboration aims to enhance access to innovative solutions and treatments for patients in the United Arab Emirates (UAE) and beyond.
  • Through our research collaboration with the Abu Dhabi Department of Health we intend to leverage our collective knowledge, experience, and expertise to further advance biomedical science and enhance public health.

The Department of Health - Abu Dhabi, Mass General Brigham, and International Center for Genetic Disease sign Declaration of Collaboration to Advance Life Sciences Research

Retrieved on: 
Wednesday, June 14, 2023
Interim, International Center, Abu Dhabi Department of Education and Knowledge, Public, Scottish Aquaculture Innovation Centre, ABU, Massachusetts General Hospital, Genomics, United Arab Emirates, Capacity building, Department of Health (Abu Dhabi), DSM-IV codes, Patient, Mass, Mass General Brigham, Emirate, Rare, Doh, Neurology, Technology transfer, Medical device, Research

ABU DHABI, UAE, June 14, 2023 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, signed a Declaration of Collaboration with Mass General Brigham's International Center for Genetic Disease (iCGD).

Key Points: 
  • ABU DHABI, UAE, June 14, 2023 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, signed a Declaration of Collaboration with Mass General Brigham's International Center for Genetic Disease (iCGD).
  • The agreement signed is intended to advance life sciences across three strategic pillars including clinical and translational research, capacity building and technology transfer and commercialisation.
  • The collaboration aims to enhance access to innovative solutions and treatments for patients in the United Arab Emirates (UAE) and beyond.
  • Through our research collaboration with the Abu Dhabi Department of Health we intend to leverage our collective knowledge, experience, and expertise to further advance biomedical science and enhance public health.

DoH and MSD GCC expand partnership during BIO International Convention 2023 to advance research in Oncology

Retrieved on: 
Friday, June 9, 2023
MSD, Triple-negative breast cancer, TNBC, Partnership, Memorandum of understanding, GCC, Public, ABU, Breast, NSCLC, Lung cancer, Government, Lung, Research and development, Innovation Center station, Department of Health (Abu Dhabi), Patient, Cancer, Knowledge, Diagnosis, Emirate, R, Doh, Health, Management, Nursing, Amusement park, Research

The agreement marks the continuation of a long-term collaboration between the two entities to advance observational research in Abu Dhabi.

Key Points: 
  • The agreement marks the continuation of a long-term collaboration between the two entities to advance observational research in Abu Dhabi.
  • The studies aim to advance the ability to address the healthcare challenges associated with these diseases and improve patient outcomes.
  • He continued: "It is with great pride that MSD joins hands with the DoH at the BIO Convention.
  • The transnational mission has culminated in Boston, coinciding with Abu Dhabi's participation at BIO International Convention 2023 to exhibit the Emirate's growth and development of its biotechnology industry.

DoH and MSD GCC expand partnership during BIO International Convention 2023 to advance research in Oncology

Retrieved on: 
Friday, June 9, 2023
MSD, Triple-negative breast cancer, TNBC, Partnership, Memorandum of understanding, GCC, Public, ABU, Breast, NSCLC, Lung cancer, Government, Lung, Research and development, Innovation Center station, Department of Health (Abu Dhabi), Patient, Cancer, Knowledge, Diagnosis, Emirate, R, Doh, Health, Management, Nursing, Amusement park, Research

The agreement marks the continuation of a long-term collaboration between the two entities to advance observational research in Abu Dhabi.

Key Points: 
  • The agreement marks the continuation of a long-term collaboration between the two entities to advance observational research in Abu Dhabi.
  • The studies aim to advance the ability to address the healthcare challenges associated with these diseases and improve patient outcomes.
  • He continued: "It is with great pride that MSD joins hands with the DoH at the BIO Convention.
  • The transnational mission has culminated in Boston, coinciding with Abu Dhabi's participation at BIO International Convention 2023 to exhibit the Emirate's growth and development of its biotechnology industry.

The Department of Health - Abu Dhabi Recognises Abu Dhabi Stem Cells Center (ADSCC) as a Centre of Excellence in Hematopoietic Stem Cell Transplantation

Retrieved on: 
Tuesday, March 28, 2023
African Centre of Excellence for Genomics of Infectious Diseases, Stem cell, Classification, Hematology, Media contacts database, Canadian Board for Respiratory Therapy, Cancer, ABU, Department of Health (Abu Dhabi), Research, Multiple sclerosis, Female, Science, Certification, MS, Regenerative medicine, Health, Steven Myers (CEO), Patient, Patient safety, Abu Dhabi Medical Congress, Excellency, Diagnosis, Emirate, Haematopoietic system, Doh, Safety, Dentistry, Hospital, Nursing, Hematopoietic stem cell transplantation, Longevity, Leukemia

Dr. Noura Al Ghaithi, Acting Undersecretary of the Department of Health - Abu Dhabi, Farhan Malik, Managing director and CEO Of PureHealth Group, Dr. Yendry Ventura, CEO of the Abu Dhabi Stem Cells Center (ADSCC), and Dr. Fatima Alkaabi, Executive Director of the Bone Marrow Transplant Program at the Abu Dhabi Stem Cells Center (ADSCC).

Key Points: 
  • Dr. Noura Al Ghaithi, Acting Undersecretary of the Department of Health - Abu Dhabi, Farhan Malik, Managing director and CEO Of PureHealth Group, Dr. Yendry Ventura, CEO of the Abu Dhabi Stem Cells Center (ADSCC), and Dr. Fatima Alkaabi, Executive Director of the Bone Marrow Transplant Program at the Abu Dhabi Stem Cells Center (ADSCC).
  • The Department of Health – Abu Dhabi outlines six key indicators that are taken into consideration when evaluating whether the healthcare facility can be recognised as a Centre of Excellence.
  • Following the announcement, Shaista Asif Group Chief Operating Officer of PureHealth said: "The selection of the Abu Dhabi Stem Cell Center as a center of excellence in Hematopoietic Stem Cell Transplantation is a prestigious honor.
  • The Abu Dhabi Bone Marrow Transplant Programme provides treatment to all patients through the Abu Dhabi Stem Cells Center as well as Yas Clinic Hospital Khalifa City.

The Department of Health - Abu Dhabi Recognises Abu Dhabi Stem Cells Center (ADSCC) as a Centre of Excellence in Hematopoietic Stem Cell Transplantation

Retrieved on: 
Tuesday, March 28, 2023
African Centre of Excellence for Genomics of Infectious Diseases, Stem cell, Classification, Hematology, Media contacts database, Canadian Board for Respiratory Therapy, Cancer, ABU, Department of Health (Abu Dhabi), Research, Multiple sclerosis, Female, Science, Certification, MS, Regenerative medicine, Health, Steven Myers (CEO), Patient, Patient safety, Abu Dhabi Medical Congress, Excellency, Diagnosis, Emirate, Haematopoietic system, Doh, Safety, Dentistry, Hospital, Nursing, Hematopoietic stem cell transplantation, Longevity, Leukemia

Dr. Noura Al Ghaithi, Acting Undersecretary of the Department of Health - Abu Dhabi, Farhan Malik, Managing director and CEO Of PureHealth Group, Dr. Yendry Ventura, CEO of the Abu Dhabi Stem Cells Center (ADSCC), and Dr. Fatima Alkaabi, Executive Director of the Bone Marrow Transplant Program at the Abu Dhabi Stem Cells Center (ADSCC).

Key Points: 
  • Dr. Noura Al Ghaithi, Acting Undersecretary of the Department of Health - Abu Dhabi, Farhan Malik, Managing director and CEO Of PureHealth Group, Dr. Yendry Ventura, CEO of the Abu Dhabi Stem Cells Center (ADSCC), and Dr. Fatima Alkaabi, Executive Director of the Bone Marrow Transplant Program at the Abu Dhabi Stem Cells Center (ADSCC).
  • The Department of Health – Abu Dhabi outlines six key indicators that are taken into consideration when evaluating whether the healthcare facility can be recognised as a Centre of Excellence.
  • Following the announcement, Shaista Asif Group Chief Operating Officer of PureHealth said: "The selection of the Abu Dhabi Stem Cell Center as a center of excellence in Hematopoietic Stem Cell Transplantation is a prestigious honor.
  • The Abu Dhabi Bone Marrow Transplant Programme provides treatment to all patients through the Abu Dhabi Stem Cells Center as well as Yas Clinic Hospital Khalifa City.

Neustar Security Services Launches UltraDDR for Enhanced DNS-based User Protection

Retrieved on: 
Wednesday, February 1, 2023
Software, Networks, Internet, Data Management, Technology, Online Privacy, Mobile, Wireless, Security, Neustar, Noise, TLS, Attack, MacOS, Organization, Dot, Fear, Intelligence, EDR, Policy, NDR, DNSSEC, HTTPS, IOS, Doh, Communication, Gambling, DNS, Social media, Android, Cryptocurrency, Microsoft Windows

Neustar Security Services , a leading provider of cloud-based security services that enable global businesses to thrive online, is introducing UltraDDR (DNS Detection and Response), a recursive DNS-based protection service aimed at combatting network breaches, ransomware attacks, phishing and supply chain compromise, while enforcing enterprise acceptable use policies for its users.

Key Points: 
  • Neustar Security Services , a leading provider of cloud-based security services that enable global businesses to thrive online, is introducing UltraDDR (DNS Detection and Response), a recursive DNS-based protection service aimed at combatting network breaches, ransomware attacks, phishing and supply chain compromise, while enforcing enterprise acceptable use policies for its users.
  • UltraDDR provides a Protective DNS solution that enables enterprises to get in front of threats by blocking communication before damage can occur.
  • UltraDDR’s real-time detection and response capabilities can help prevent user actions from becoming an enterprise’s biggest security blind spot.”
    Organizations can depend on UltraDDR for their recursive DNS needs.
  • Additionally, the service includes built-in DNS DDoS protection via Neustar Security Services’ UltraDDoS Protect solution to quickly defend against attacks towards the UltraDDR DNS resolver network, ensuring that DNS resolution availability is not compromised.

Amarin Appoints Adam Berger and Geraldine Murphy to Board of Directors

Retrieved on: 
Thursday, October 20, 2022
Decision-making, U.S. Securities and Exchange Commission, Securities Act of 1933, Cardiovascular disease, Risk, Health care, SEC, Citigroup, Growth, Review, Science, Partner, Doh, Â, Professional corporation, NASDAQ, National, Security (finance), Annual report, Wells Fargo, Company, Department, FAQ, Brother, Department of Health (Philippines), Board, Association, M&A, Director, File, GLOBE, ABPI, Record, Chief executive officer, Retirement, Leadership, Management, Pharmaceutical industry, Amarin Corporation

DUBLIN, Ireland and BRIDGEWATER, N.J., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced the appointment of Adam Berger and Geraldine Murphy as independent members of the Companys Board of Directors, effective immediately.

Key Points: 
  • DUBLIN, Ireland and BRIDGEWATER, N.J., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced the appointment of Adam Berger and Geraldine Murphy as independent members of the Companys Board of Directors, effective immediately.
  • Mr. Wold-Olsen continued, On behalf of the entire Board, I also want to express our deep gratitude to Lars and Paddy for their leadership, tenure, and dedication to the Amarin Board.
  • Mr. Berger has more than three decades of experience with investment banking focused on mergers and acquisitions.
  • Ms. Murphy has a strong focus on people and organizational development which will be of significant value to Amarin and the Amarin Board.

OpenText Unveils Cloud Editions 22.3, Unleashing Exponential Innovation as Project Titanium Roadmap Takes Off

Retrieved on: 
Thursday, August 4, 2022
Cloud, API, Multimedia, Documentation, IOS, Content, SEC, Ecosystem, TSX, Information management, The Information (company), Research, Intelligence, CE, Annual report, Compliance, Marketing, DNS, Review, List of life sciences, CTO, Leak, NASDAQ, Intention, YouTube, Social media, Hootsuite, All rights reserved, UI, CDN, Doh, Solution, Time, Publishing, HTTPS, OpenText, Efficiency, Organization, Video game console, Cryptocurrency, Risk management

WATERLOO, ON, Aug. 4, 2022 /PRNewswire/ -- Today, OpenText™ (NASDAQ: OTEX), (TSX: OTEX), announced Cloud Editions 22.3 (CE 22.3). Building on its 90-day release cycles for new capabilities, this new set of innovations from OpenText on their Project Titanium roadmap is fueling the future for more integrated information management in the cloud.

Key Points: 
  • Building on its 90-day release cycles for new capabilities, this new set of innovations from OpenText on their Project Titanium roadmap is fueling the future for more integrated information management in the cloud.
  • OpenText is leading the way, enabling businesses to realize sustained business value through the information advantage.
  • CE 22.3 innovations highlight where OpenText is going to enable customers to consume how they want, whether that is in a private cloud, in the public cloud, via cloud API services, or off-cloud.
  • OpenText, The Information Company, enables organizations to gain insight through market leading information management solutions, powered by OpenText Cloud Editions.